9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts

Retinoic acid (RA) therapy has been utilized as maintenance therapy for high-risk neuroblastoma, but over half of patients treated with RA relapse. Neuroblastoma stem cell-like cancer cells (SCLCCs) are a subpopulation of cells characterized by the expression of the cell surface marker CD133 and are...

Descripción completa

Detalles Bibliográficos
Autores principales: Marayati, Raoud, Bownes, Laura V., Stafman, Laura L., Williams, Adele P., Quinn, Colin H., Atigadda, Venkatram, Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Beierle, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530346/
https://www.ncbi.nlm.nih.gov/pubmed/33010553
http://dx.doi.org/10.1016/j.tranon.2020.100893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530346/
https://www.ncbi.nlm.nih.gov/pubmed/33010553
http://dx.doi.org/10.1016/j.tranon.2020.100893

Ejemplares similares